Samantha Jaglowski

Samantha Jaglowski, MD

Physician

Make an Appointment

Specialty

Overall Patient Satisfaction Rating

stars
4.9 out of 5
44
Reviews
4
Comments

Gender

Female

Biography


I’m a hematologist specializing in stem cell transplants for patients battling lymphoma and chronic lympocytic leukemia. I am an associate professor of hematology and the medical director of the Blood and Marrow Transplant Program.

As a practitioner and a researcher, I’m very focused on survivorship and the challenges patients face once they receive their life-saving therapies, as well as improving those therapies to try to reduce long-term complications of transplant.

At The James, I’m inspired by how focused everyone is on the patient and the patient’s experience—from the CEO to the custodial staff. It’s amazing to work every day in a place that’s leading our generation’s fight against cancer, but without ever losing sight of the real people who are at the center of it.

I’m proud of my long connection to OSU. I started my career here as an undergraduate zoology major. I received my medical degree and masters degree in Public Health from OSU, as well. Throughout my career, I have received honors and awards from OSU, the American Society of Hematology, the American Society of Blood and Marrow Transplantation, and the American Society of Clinical Oncology. Additionally, my research has been published in the Journal of Clinical Investigation, Blood, the New England Journal of Medicine and elsewhere.

Education and Background

Education

Ohio State University College of Medicine

Columbus, OH

Residencies

Ohio State University Wexner Medical Center

Columbus, OH

Fellowship

Hematology/Oncology

Ohio State University Wexner Medical Center

Columbus, OH

Hematology/Oncology

Ohio State University Wexner Medical Center

Columbus, OH

Board Certifications

American Board of Internal Medicine

American Board of Internal Medicine (Subspecialty: Medicine Oncology)

Academic Department

Department of Internal Medicine

Division of Hematology


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 12/20/2018, Dr. Jaglowski has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

Amgen, Inc.

Gilead Sciences, Inc.

Novartis

i3Health

Juno

Reviews

Patient Satisfaction Review

The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.

Overall Ratings (out of 44 reviews)
stars
4.9 out of 5
Kept you informed about your condition and treatment

4.8/ 5

Amount of time spent with you

4.8/ 5

Concern for your questions and issues

4.9/ 5

Skill and knowledge

4.9/ 5

Overall quality of care

4.9/ 5

Patient Comments (4 total comments)

stars
Reviewed: 5/12/2019

Love Dr. Jaglowski! I appreciate that she promptly respondd to email inquiries

stars
Reviewed: 4/25/2019

Dr. Jaglowski is exceptional. She addresses all my needs. She takes time to talk to me, and follows up if I have concerns or problems. She is the best. I feel so fortunate to have her as my doctor. I would recommend her or The James to anyone.

stars
Reviewed: 2/20/2019

Incredible time to discuss all of our questions, concerns & anxieties.

stars
Reviewed: 1/20/2019

She is the best doctor I ever had. She is very passionate about her patients and give them the best care she can and she is very knowledgeable.

Publications

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Yucebay F, Matthews C, Puto M, Li J, William B, Jaglowski SM, Penza SL, Vasu S, Benson DM, Andritsos LA, Devine SM, Efebera YA, Roddy JVF

Leuk Lymphoma in press

2/15/2019

BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas.

Singer S, Sharma N, Dean R, Zhao Q, Abounader D, Elder P, Hofmeister CC, Benson DM, Rosko A, Penza S, Andritsos L, Vasu S, Jaglowski S, William BM, Bolwell B, Pohlman B, Kalaycio M, Jagadeesh D, Hill B, Sobecks R, Devine SM, Majhail NS, Efebera YA

Bone Marrow Transplant in press

2/4/2019

Clinical Trials | Lead

OSU-15286

ALLIANCE-A051301

OSU-17007

Related Videos

FDA Approves CAR-T for Aggressive Lymphoma
New Graft vs. Host Disease Findings Could Improve Leukemia Treatment
New Therapy for Childhood Leukemia In Studies to Determine Success in Adult Treatments, Too
Back to Find a Doctor Search

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR